M65 TFA

M65 TFA is a deleted peptide of maxadilan (61 a.a.) with deletion of the residues between positions 24 and 42 and is a specific antagonist of PACAP type 1 receptor that inhibits ANP secretion and can be used for relevant researches[1][2].

C205H326N64O61S5.xC2HF3O2

O=C([C@@H](N)CSSC[C@H](NC1=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]3CCC(O)=O)=O)CCCCN)=O)CC4=CC=CC=C4)=O)C(C)C)=O)CO)=O)CC(N)=O)=O)=O)CCC2)=O)C(C)C)=O)CC(N)=O)=O)CO)=O)CC5=CNC=N5)=O)CC6=CNC=N6)=O)C)=O)CCC(N)=O)=O)CCCCN)=O)CCC(N)=O)=O)CSSC[C@H](NC3=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C)=O)CCCCN)=O)CC7=CC=CC=C7)=O)CCC(O)=O)=O)CCCCN)=O)CCCCN)=O)CCCCN)=O)CCC(N)=O)=O)CCCCN)=O)CCSC)=O)=O)CC(O)=O)=O)CC(O)=O)=O)[C@H](CC)C)=O)C)=O)CCCCN)=O)CCCNC(N)=N)=O)CC8=CC=CC=C8)=O)CCC(N)=O)=O)N[C@H](C(N[C@H](C(N[C@H]1[C@@H](C)O)=O)C)=O)CC(O)=O.OC(C(F)(F)F)=O.[x]

PACAP Receptor

99.98

DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Blue Ice